Fintel reports that on July 23, 2025, Wells Fargo downgraded their outlook for Centene (NYSE:CNC) from Overweight to ...

Centene Corporation (NYSE:CNC) is one of the Best Beaten Down Stocks to Buy Now. Bank of America downgraded the company’s ...

Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...

Fintel reports that on July 21, 2025, TD Cowen downgraded their outlook for Centene (NYSE:CNC) from Buy to Hold. Analyst ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

Investing.com - JPMorgan downgraded Centene (NYSE:CNC), a $28.19 billion healthcare provider trading at 8.46x earnings, from Overweight to Neutral on Tuesday, slashing its price target to $48.00 ...

Centene Corp. : Though BofA Securities upgraded it to Neutral from Underperform, the analyst also cut the $79 target price to $72. The consensus target is $82.06. Tuesday’s close was at $61.88.

Key Takeaways From Centene Analyst Ratings October 25, 2024 — 09:00 am EDT Written by Benzinga Insights for Benzinga -> ...

Centene Stock: A Deep Dive Into Analyst Perspectives (8 Ratings) December 10, 2024 — 09:01 am EST Written by Benzinga Insights for Benzinga -> ...

Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...